Expression of Markers Related to Mitochondrial Functionality in Carcinoma of the Urinary Bladder: Comparative Retrospective Analysis Between Recurrent Tumors ("Non-responders") and Non-recurrent Tumors ("Responders") After Intravesical Treatment With Chemotherapy or Immunotherapy
NCT04256122 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200
Last updated 2020-02-17
Summary
Retrospective monocentric study evaluating different immunohistochemical phenotypes related to mitochondrial functions with treatment outcomes
Conditions
Interventions
- OTHER
-
No intervantion on patients. retrospective study is performed on paraffin embedded tumor tissue specimens routinely collected during TURBT.
evaluate an immunophenotypical profile related to mitochondrial functions in tumors responders vs non-responder to intravescical chemotherapy or immunotherapy. Verify the possible prognostic differences in clinical behavior between the two populations.
Sponsors & Collaborators
-
Istituto Clinico Humanitas
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-10-22
- Primary Completion
- 2020-10-31
- Completion
- 2020-12-31
Countries
- Italy
Study Locations
More Related Trials
-
Diagnostic Performance and Predictive Capacity of Immediate Urine Cytology After Transurethral Resection of Non-Muscle Invasive Bladder Cancer; A Prospective Study
NCT04194112 ·Status: COMPLETED ·Phase: NA
-
Tumorspecific T-cell Immunity in Bladder Cancer as Prognostic Marker
NCT01198808 ·Status: UNKNOWN
-
Sequential Bacillus Calmette-Guérin (BCG) and Electromotive Mitomycin-C Versus Bacillus Calmette-Guérin (BCG) Alone for High Risk Superficial Bladder Cancer
NCT01442519 ·Status: COMPLETED ·Phase: PHASE3
-
The Effectiveness and Safety of Neoadjuvant Intravesical Mitomycin-C Instillation
NCT03058757 ·Status: COMPLETED ·Phase: PHASE2
-
The Potential Role Of MicroRNA-155 And Telomerase Reverse Transcriptase In Diagnosis Of Non-Muscle Invasive Bladder Cancer And Their Pathological Correlation
NCT03591367 ·Status: COMPLETED ·Phase: NA
-
Therapeutic Instillation of Mistletoe
NCT02106572 ·Status: TERMINATED ·Phase: PHASE3
-
Prognostic Biomarkers in Patients With Urothelial Carcinoma
NCT04872036 ·Status: COMPLETED
-
A Study to Evaluate Efficacy and Safety of Hydeal Cyst® Intravesical Instillations in Patients Treated With Intravesical Chemotherapy or Immunotherapy in Non-muscle Invasive Bladder Cancer
NCT06245603 ·Status: RECRUITING ·Phase: NA
-
Microscopic-spectroscopic Examination for Urothelial Tissue Characterization
NCT04310813 ·Status: COMPLETED
-
An Open, Dose-escalation Clinical Study of Chimeric Exosomal Tumor Vaccines for Recurrent or Metastatic Bladder Cancer
NCT05559177 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Safety and Tolerability Study Which Evaluate Intravesical Instillation With Mitomycin C Mixed With TC-3 Drug Retaining Hydrogel Device In Patients With Muscle Invasive Bladder Cancer
NCT01648010 ·Status: COMPLETED ·Phase: NA
-
Analysis of Urinary Methylation Patterns Via Liquid Biopsy as an Early Diagnosis Tool
NCT06878027 ·Status: RECRUITING
-
Study on the Quality of Life and Pathological State in Patients Who Underwent Radical Cystectomy
NCT06170177 ·Status: RECRUITING
-
Research on the Accurate Diagnosis of Urinary Tract Tumors and the Development of Kits
NCT06193941 ·Status: COMPLETED
-
ALDOA Expression in Bladder Urothelial Carcinoma
NCT06550947 ·Status: NOT_YET_RECRUITING
-
Urothelial Cancer Tumor Bio-markers and Physical-spectroscopic Characteristic
NCT04770974 ·Status: UNKNOWN
-
Quality of Life After Treatment for Bladder Cancer: The Bladder Cancer Survivorship Study
NCT06350734 ·Status: ACTIVE_NOT_RECRUITING
-
Preoperative Intravesical Electromotive Mitomycin-c for Primary Non-muscle Invasive Bladder Cancer
NCT01149174 ·Status: COMPLETED ·Phase: PHASE3
-
Investigating the Efficacy and Safety of Neoadjuvant Intravesical Instillation of Mitomycin C in Treating High-risk NMIBC Patients
NCT06696794 ·Status: RECRUITING ·Phase: PHASE3
-
A Multicenter Prospective Cohort Study on Monitoring Recurrence of Urothelial Carcinoma Based on Detection of Urinary Microscopic Residual Disease (MRD)
NCT06991868 ·Status: RECRUITING
-
Expression of MCM5 in Urine in Patients With Urothelial Cancers
NCT03796299 ·Status: UNKNOWN
-
Bio Clinical Collection of Urothelial Carcinoma
NCT04970472 ·Status: RECRUITING
-
Sequential Combination Therapy in Bladder Cancer
NCT03790384 ·Status: UNKNOWN ·Phase: PHASE4
-
Intravesical Gemcitabine Instillation Followed by Transurethral Resection for the Treatment of Patients With Superficial Bladder Cancer at Low Risk.
NCT00191711 ·Status: COMPLETED ·Phase: PHASE2
-
Care of the Urothelial Cancer Patient and Prospective Procurement of Urothelial Cancer Tissue
NCT02379429 ·Status: RECRUITING